ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ Technology
Portfolio Pulse from
ReShape Lifesciences has received a $241,000 NIH supplementary grant in collaboration with USC's CARSS to advance its Diabetes Bloc-Stim Neuromodulation technology. The grant will fund research on laparoscopic surgical electrode implantation and blood glucose modulation.
November 11, 2024 | 1:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ReShape Lifesciences received a $241,000 NIH grant to develop its Diabetes Bloc-Stim Neuromodulation technology with USC's CARSS. This funding supports research on electrode implantation and glucose modulation, potentially advancing their product pipeline.
The NIH grant provides financial support for ReShape Lifesciences to further develop its proprietary technology, which could lead to advancements in their product offerings. This is likely to be viewed positively by investors as it enhances the company's research capabilities and potential market offerings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90